Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease

International Journal of Cardiovascular Imaging

Volumn 28, Issue 2, 2012, Pages 431-438

  Noordzij, Marjon J ^a   Lefrandt, Joop D ^a   Loeffen, Erik A H ^a   Saleem, Ben R ^a   Meerwaldt, Robbert ^b   Lutgers, Helen L ^a   Smit, Andries J ^a   Zeebregts, Clark J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Advanced glycation end products; Carotid artery stenosis; Peripheral vascular disease; Skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGE DETERMINATION; AGED; ARTICLE; AUTOFLUORESCENCE IMAGING; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK ASSESSMENT; SKIN AUTOFLUORESCENCE; SMOKING HABIT;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; CAROTID STENOSIS; CASE-CONTROL STUDIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; RISK FACTORS; SKIN; SPECTROMETRY, FLUORESCENCE; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UP-REGULATION;

EID: 84861480140     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9805-6     Document Type: Article

References (22)

1. Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114:597-605 (Pubitemid 44199649)
2. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, Cleary PA, Lachin J, Genuth S (1999) Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 48:870-880 (Pubitemid 29153089)
3. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO, Smit AJ (2006) Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 29:2654-2659 (Pubitemid 44912194)
4. Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234
5. Yoshida N, Okumura K, Aso Y (2005) High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 54:345-350 (Pubitemid 40250094)
6. Meerwaldt R, van der Vaart MG, van Dam GM, Tio RA, Hillebrands JL, Smit AJ, Zeebregts CJ (2008) Clinical relevance of advanced glycation endproducts for vascular surgery. Eur J Vasc Endovasc Surg 36:125-131 (Pubitemid 351952326)
7. Basta G (2008) Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 196:9-21
8. Baynes JW, Thorpe SR (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28:1708-1716 (Pubitemid 30628657)
9. Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A (2005) Simple noninvasive measurement of skin autofluorescence. Ann NY Acad Sci 1043:290-298 (Pubitemid 41123918)
10. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ (2004) Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47:1324-1330 (Pubitemid 39093330)
11. Mulder DJ, Water TV, Lutgers HL, Graaff R, Gans RO, Zijlstra F, Smit AJ (2006) Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 8:523-535 (Pubitemid 44946877)
12. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO, Smit AJ (2007) Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30:107-112 (Pubitemid 46052507)
13. Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son WJ, de Jong PE, Smit AJ (2005) Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann NY Acad Sci 1043:299-307 (Pubitemid 41123919)
14. Mulder DJ, van Haelst PL, Gross S, de Leeuw K, Bijzet J, Graaff R, Gans RO, Zijlstra F, Smit AJ (2008) Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 197:217-223 (Pubitemid 351273241)
15. Suliman ME, Stenvinkel P, Jogestrand T, Maruyama Y, Qureshi AR, Barany P, Heimburger O, Lindholm B (2006) Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy. Clin Nephrol 66:418-425 (Pubitemid 44896150)
16. Baumann M, Richart T, Sollinger D, Pelisek J, Roos M, Kouznetsova T, Eckstein HH, Heemann U, Staessen J (2009) Association between carotid diameter and the advanced glycation endproduct Nepsilon-Carboxymethyllysine (CML). Cardiovasc Diabetol 8:45
17. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R (2010) Reference values of skin autofluorescence. Diabetes Technol Ther 12:399-403
18. Stirban A, Nandrean S, Negrean M, Koschinsky T, Tschoepe D (2008) Skin autofluorescence increases postprandially in human subjects. Diabetes Technol Ther 10:200-205 (Pubitemid 351677591)
19. Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ (2010) Skin autofluorescence and glycemic variability. Diabetes Technol Ther 12:581-585
20. Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-years progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 54:3103-3111 (Pubitemid 43334362)
21. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ (2009) Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 52:789-797
22. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, Thorpe SR, Baynes JW, Navis G, Gans RO, Smit AJ (2005) Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 16:3687-3693 (Pubitemid 46211290)